The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patients.
about
Therapeutic drug monitoring of antiretrovirals for people with HIVA randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients.A randomized clinical trial evaluating therapeutic drug monitoring (TDM) for protease inhibitor-based regimens in antiretroviral-experienced HIV-infected individuals: week 48 results of the A5146 study.Individualization of antiretroviral therapy.
P2860
The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The design and implementation ...... rienced HIV-infected patients.
@en
type
label
The design and implementation ...... rienced HIV-infected patients.
@en
prefLabel
The design and implementation ...... rienced HIV-infected patients.
@en
P2093
P2860
P356
P1433
P1476
The design and implementation ...... rienced HIV-infected patients.
@en
P2093
A Lisa Mukherjee
Alex R Rinehart
Barbara Bastow
Gene D Morse
Hongyu Jiang
Lisa M Demeter
Mary Albrecht
Robert DiCenzo
Robin DiFrancesco
P2860
P356
10.1310/HCT0901-61
P577
2008-01-01T00:00:00Z